The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Biodegradable poly(ε-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
On the importance and mechanisms of burst release in matrix-controlled drug delivery systems
Huang, X., & Brazel, C. S. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00248-6 · Cited by 1,813
Barriers to Drug Delivery in Solid Tumors
Jain, R. K. (1994) · Scientific American · doi:10.1038/scientificamerican0794-58 · Cited by 1,069
Tietz Fundamentals of Clinical Chemistry
Burtis, E. B. C. A., & Ashwood, E. R. (1996) · Cited by 919
Controlled Delivery Systems for Proteins Based on Poly(Lactic/Glycolic Acid) Microspheres
Cohen, S., Yoshioka, T., Lucarelli, M., Hwang, L. H., & Langer, R. (1991) · Pharmaceutical Research · doi:10.1023/a:1015841715384 · Cited by 843
Basic Guide to the Mechanisms of Antiestrogen Action
Macgregor, J. I., & Jordan, V. C. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01358-9 · Cited by 694
Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture.
Lerner, L. J., & Jordan, V. C. (1990) · PubMed · Cited by 417
Fighting Cancer by Attacking its Blood Supply
Folkman, J. (1996) · Scientific American · doi:10.1038/scientificamerican0996-150 · Cited by 328
Polycaprolactone microparticles and their biodegradation
Chen, D. R., Bei, J. Z., & Wang, S. G. (2000) · Polymer Degradation and Stability · doi:10.1016/s0141-3910(99)00145-7 · Cited by 316
Cited by
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146315 · Cited by 1,577
In Vitro Cytotoxicity of Nanoparticles in Mammalian Germline Stem Cells
Braydich-Stolle, L., Hussain, S., Schlager, J. J., & Hofmann, M.-C. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi256 · Cited by 1,247
Poly-ϵ-caprolactone microspheres and nanospheres: an overview
Sinha, V. R., Bansal, K., Kaushik, R., Kumria, R., & Trehan, A. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.01.044 · Cited by 1,100
Nanoparticles for drug delivery: The need for precision in reporting particle size parameters
Gaumet, M., Vargas, A., Gurny, R., & Delie, F. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.08.001 · Cited by 1,081
Metadata
- Authors
- Chawla, J. S., & Amiji, M. M.
- Venue
- International Journal of Pharmaceutics
- Publisher
- Elsevier BV
- Published
- 2002-12
- Volume
- 249
- Issue
- 1-2
- Pages
- 127-138
- ISSN
- 0378-5173 (ISSN-L)
- OpenAlex
- W2160271899
- Cited by
- 487
- References
- 19
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biodegradable poly(ε-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. https://app.cochat.ai/papers/10.1016/s0378-5173(02)00483-0
- The paper
- Chawla, J. S., & Amiji, M. M. (2002). Biodegradable poly(ε-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. International Journal of Pharmaceutics. https://doi.org/10.1016/s0378-5173(02)00483-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.